In contrast, NASPGHAN advocates screening by alanine aminotransferase (ALT), but does not recommend ultrasound (US) due to low sensitivity in all children with overweight and obesity and additional risk factors at age 9-11 years (50). The gene discussed is GPT; the disease is obesity due to melanocortin 4 receptor deficiency.